Home Ingredients Potassium Citrate
Bone HealthKidney/Urinary Tract

Potassium Citrate

Evidence Level
Strong
2 Clinical Trials
5 Documented Benefits
4/5 Evidence Score

Potassium citrate is potassium combined with citric acid — distinct from potassium chloride (most common supplemental form) by its alkalinizing effect and FDA-approved use for kidney stone prevention (Urocit-K® prescription). Lower risk of GI ulceration than potassium chloride. Used both as nutritional potassium and as urinary alkalinizer for calcium oxalate, uric acid, and cystine stone prevention.

Studied Dose Nutritional: 100-500 mg/day; Pharmaceutical for stones: 30-90 mEq/day (Urocit-K®, prescription)
Active Compound Potassium citrate (tripotassium citrate)

Benefits

Kidney Stone Prevention (FDA-Approved)

Potassium citrate is FDA-APPROVED (Urocit-K® prescription) for prevention of calcium oxalate, uric acid, and cystine kidney stones. Mechanism: raises urinary citrate (which inhibits calcium oxalate crystallization) and urinary pH (which prevents uric acid stones). Standard urology care for recurrent stone-formers.

Supported by Trial 1

Urinary Alkalinizer

Citrate metabolizes to bicarbonate — raises urinary pH. Used for: gout (uric acid stones), cystinuria (cystine stones), and adjunct in some chemotherapy protocols (urinary alkalinization to reduce kidney damage).

Supported by Trial 1

Bone Health (Modest Evidence)

Potassium citrate may modestly support bone health by buffering metabolic acid load (typical Western diets are net-acid-producing). Some evidence for reduced bone resorption markers; effect modest. Whole-diet approach (DASH, Mediterranean) more impactful than single supplement.

Supported by Trial 2

Blood Pressure (Unproven for This Form)

Adequate potassium intake is associated with lower blood pressure across populations, and potassium citrate supplies potassium without the GI ulceration risk of potassium chloride. The one randomized trial that tested potassium citrate directly (40 mmol/day in people with early hypertension) found no significant change in blood pressure or vascular function, so a blood-pressure benefit is unproven for this form specifically.

Supported by Trial 2, Trial 1

Lower GI Toxicity than Potassium Chloride

Potassium chloride tablets can cause GI ulceration if not adequately diluted. Potassium citrate has less GI toxicity — preferred for patients sensitive to chloride forms or with prior GI issues.

Supported by Trial 1, Trial 2

Mechanism of action

1

Citrate to Bicarbonate Conversion

Absorbed citrate is metabolized in liver to bicarbonate — neutralizes metabolic acid load and raises urinary pH. Urinary citrate excretion increases, providing the stone-prevention mechanism.

2

Calcium Oxalate Stone Inhibition

Urinary citrate binds calcium and reduces calcium oxalate supersaturation — major mechanism for calcium oxalate stone prevention. Hypocitraturia is a major risk factor for these stones.

3

Urinary pH Elevation

Raised urinary pH prevents uric acid stone formation (uric acid is more soluble at higher pH) and cystine stone formation. Targeted pH 6.5-7.0 for stone prevention.

4

Acid-Base Buffering

Bicarbonate generation buffers chronic mild metabolic acidosis from typical Western diets — proposed mechanism for bone-sparing effects.

Clinical trials

1
Potassium Citrate for Calcium Oxalate Stone Prevention — Trials
PubMed

Multiple clinical trials of potassium citrate (30-60 mEq/day) for prevention of recurrent calcium oxalate kidney stones.

Recurrent calcium oxalate stone-formers.

Potassium citrate significantly reduces recurrent stone formation vs placebo. Standard urology care; recommended in AUA stone prevention guidelines.

2
Potassium Citrate for Bone Health
PubMed

Randomized controlled trial of potassium citrate on bone turnover markers and bone density in postmenopausal women with osteopenia (Jehle et al. 2006).

Pooled across bone health clinical trials.

Potassium citrate modestly reduces bone resorption markers and may slow bone loss. Effect sizes modest. Bone density changes inconsistent across trials. Adjunctive role only.

Side effects and drug interactions

Common Potential side effects

GI upset (nausea, diarrhea) — generally mild.
Hyperkalemia risk in CKD or with potassium-sparing medications — potentially fatal.
Pill burden — therapeutic stone-prevention doses require multiple large pills.
Metallic/salty taste with liquid forms.
Less GI ulceration than potassium chloride (relative advantage).

Important Drug interactions

ACE inhibitors / ARBs — increase potassium retention; hyperkalemia risk; monitor potassium.
Aldosterone antagonists (spironolactone, eplerenone) — hyperkalemia risk; very serious; monitor closely.
Potassium-sparing diuretics (amiloride, triamterene) — hyperkalemia risk.
NSAIDs — reduce potassium excretion modestly.
Trimethoprim — reduces potassium excretion; potential hyperkalemia.
Heparin — reduces potassium excretion.
Tetracyclines/quinolones — chelation; separate by 2 hours.
Aluminum-containing drugs — citrate enhances aluminum absorption; caution in CKD/dialysis.

Featured in these supplement guides

Lower Blood Pressure→

More Bone Health Ingredients

Bone Health
Vitamin D
Vitamin D is a fat-soluble vitamin and steroid hormone precursor essential for calcium abs…
Bone Health
Calcium
Calcium is the most abundant mineral in the body — about 99% stored in bones and teeth, wi…
Bone Health
Vitamin K
Vitamin K is a fat-soluble vitamin essential for blood clotting and for directing calcium…
Bone Health
Copper
Copper is an essential trace mineral that a number of enzymes need in order to work, inclu…

Related articles from our blog

📝 Article
Supplements for Kidney Stones: What the Evidence Supports
Kidney stones are one of those problems where the internet advice and the actual evidence point in different directions,…

Frequently asked questions about Potassium Citrate

What is potassium citrate used for?

Potassium citrate provides potassium in an alkalizing form, and is notably used to help prevent certain kidney stones by making urine less acidic and raising urinary citrate. It also supports bone and a healthy acid-base balance.

Does potassium citrate help with kidney stones?

Yes, it is a recognized tool (often by prescription) for reducing the formation of calcium and uric acid kidney stones, because it raises urine citrate and pH, which discourages stone crystals. Use it for this purpose under a doctor's guidance.

How much potassium citrate should I take?

Over-the-counter potassium is limited to 99 mg per serving; the higher doses used for kidney stones or bone are prescription-strength and medically supervised. For general use, most potassium should come from fruits and vegetables.

Is potassium citrate safe?

At small supplemental amounts it is generally well tolerated and gentler than potassium chloride. People with kidney disease or on potassium-raising medications should avoid it without medical supervision, due to the risk of high potassium.

What is Potassium Citrate?

Potassium citrate is potassium combined with citric acid — distinct from potassium chloride (most common supplemental form) by its alkalinizing effect and FDA-approved use for kidney stone prevention (Urocit-K® prescription). Lower risk of GI ulceration than potassium chloride.

What is the recommended dosage of Potassium Citrate?

The clinically studied dose is Nutritional: 100-500 mg/day; Pharmaceutical for stones: 30-90 mEq/day (Urocit-K®, prescription) Always follow the product label and check with a healthcare provider for personal advice.

Is Potassium Citrate safe, and does it have side effects?

For most healthy adults, Potassium Citrate is well tolerated at studied doses. Reported effects can include: GI upset (nausea, diarrhea) — generally mild. Hyperkalemia risk in CKD or with potassium-sparing medications — potentially fatal. It may also interact with some medications. Potassium Citrate is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Potassium Citrate interact with any medications?

Possible interactions include: ACE inhibitors / ARBs — increase potassium retention; hyperkalemia risk; monitor potassium. Aldosterone antagonists (spironolactone, eplerenone) — hyperkalemia risk; very serious; monitor closely. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Potassium Citrate?

NutraSmarts rates the evidence for Potassium Citrate as Strong (4 out of 5). It is backed by 2 clinical trials and 6 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(6 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. The Journal of Urology. 1993;150(6):1761-1764. doi: 10.1016/s0022-5347(17)35888-3.PubMedUsed to support: Landmark RCT establishing the best-supported use: potassium citrate raised urinary citrate and markedly reduced calcium stone recurrence vs placebo. Honest framing: benefit is clearest in hypocitraturic stone-formers; GI upset can limit adherence.
  2. Pak CY, Sakhaee K, Fuller C Successful management of uric acid nephrolithiasis with potassium citrate. Kidney International. 1986;30(3):422-428. doi: 10.1038/ki.1986.201.PubMedUsed to support: Supports the uric-acid-stone use: potassium citrate alkalinizes urine, dissolving and preventing uric-acid stones. Honest framing: requires monitoring to avoid over-alkalinization, and it is contraindicated in hyperkalemia/renal failure.
  3. Jehle S, Zanetti A, Muser J, Hulter HN, Krapf R Partial neutralization of the acidogenic Western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia. Journal of the American Society of Nephrology. 2006;17(11):3213-3222. doi: 10.1681/ASN.2006030233.PubMedUsed to support: Supports the bone hypothesis: neutralizing dietary acid load with potassium citrate increased bone mass in osteopenic women. Honest framing: this positive bone signal is smaller and less consistent than the clear stone-prevention effect.
  4. Jehle S, Hulter HN, Krapf R Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial. The Journal of Clinical Endocrinology and Metabolism. 2013;98(1):207-217. doi: 10.1210/jc.2012-3099.PubMedUsed to support: A larger RCT showing potassium citrate improved bone density and microarchitecture in older adults. Honest framing: bone and blood-pressure benefits remain modest and mixed across trials, so stone prevention is still the strongest evidence-based use.
  5. Phillips R, Hanchanale VS, Myatt A, Somani B, Nabi G, Biyani CS. Citrate salts for preventing and treating calcium containing kidney stones in adults. Cochrane Database Syst Rev. 2015;2015(10):CD010057. doi: 10.1002/14651858.CD010057.pub2.PubMedUsed to support: Cochrane meta-analysis of 7 randomized trials (477 adults, mostly calcium oxalate stone-formers) treated for at least six months. Citrate therapy significantly lowered new stone formation versus placebo or no treatment (RR 0.26, 95% CI 0.10 to 0.68) and reduced the need for retreatment (RR 0.22, 95% CI 0.06 to 0.89). Study quality was moderate to poor and more people left the citrate groups because of gastrointestinal upset (RR 4.45), so the benefit is real but adherence limits it. This meta-analysis, alongside FDA approval and urology guidelines, is why stone prevention is the best-supported use.
  6. Berry SE, Mulla UZ, Chowienczyk PJ, Sanders TA. Increased potassium intake from fruit and vegetables or supplements does not lower blood pressure or improve vascular function in UK men and women with early hypertension: a randomised controlled trial. Br J Nutr. 2010;104(12):1839-47. doi: 10.1017/S0007114510002783.PubMedUsed to support: A randomized crossover trial in adults with early hypertension gave 40 mmol/day of potassium citrate and found no significant change in blood pressure, arterial stiffness, endothelial function or inflammatory markers, so a blood-pressure benefit is not established for this potassium form.